Scribe Therapeutics Inc. Common Stock (SCTX) — Defensive Interval Ratio
Scribe Therapeutics Inc. Common Stock (SCTX) has a Defensive Interval Ratio of 134 days as of March 2026. Defensive assets of $29.35 Million (cash $-, short-term investments $29.35 Million, receivables $-) cover 134 days of daily cash needs of $218.41K/day. For the complete balance sheet picture, see SCTX total assets.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Scribe Therapeutics Inc. Common Stock Defensive Interval Ratio (2024–2025)
This chart shows how Scribe Therapeutics Inc. Common Stock's Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of March 2026, the ratio stands at 134 days, meaning defensive assets of $29.35 Million can fund 134 days of operations without new revenue. Check SCTX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Defensive Interval Ratio for Scribe Therapeutics Inc. Common Stock (2024–2025)
The table below presents the year-by-year Defensive Interval Ratio for Scribe Therapeutics Inc. Common Stock from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 239 days | $45.17 Million | $189.20K/day | $- | $45.17 Million | ▼ -726 days |
| 2024 | 965 days | $92.57 Million | $95.94K/day | $- | $92.57 Million | — |